Home » Topics » Science » New compound

New compound
RSS

Multivalent nanobodies potently neutralize SARS-CoV-2 and prevent mutational escape

Feb. 4, 2021

PW-0787, a novel potent and brain-penetrant GPR52 agonist for neuropsychiatric disorders

Jan. 15, 2021

JMX-0207 inhibits Zika virus both in vitro and in vivo

Jan. 11, 2021

Novel urotensin II receptor antagonists show efficacy in a mouse pressor response model

Jan. 4, 2021

Preclinical evaluation of SPR-519, a novel dual PI3K-alpha and mTOR kinase inhibitor

Dec. 31, 2020

Activity against AML seen in vitro and in vivo with LSD1 inhibitor CPI-482

Dec. 31, 2020

YF17D-based COVID-19 vaccine candidate induces protective immunity within 10 days with a single dose

Dec. 30, 2020

DISC-A demonstrates efficacy in low hepcidin rat model

Dec. 28, 2020

GBT-021601 improves the pathophysiology of sickle cell disease in vivo

Dec. 23, 2020

Discovery of new PDIA1 inhibitor with antitumor activity in models of multiple myeloma

Dec. 21, 2020

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...